Femasys (FEMY) Capital Expenditures (2020 - 2026)
Femasys' (FEMY) quarterly Capital Expenditures came in at $79138.0 in Q1 2026, down 18.08% YoY from $96605.0 in Q1 2025, and down 43.41% on a QoQ basis from $139840.0 in Q4 2025.
Femasys (FEMY) Capital Expenditures (2020 - 2026) Analysis & Trends
Femasys (FEMY) has 7 years of Capital Expenditures data on file, last reported at $79138.0 in Q1 2026.
- Quarterly Capital Expenditures fell 18.08% year-over-year to $79138.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $507540.0 (down 36.06% YoY) and the FY2025 annual result came in at $525007.0, down 31.07% from the prior year.
- Capital Expenditures retreated to $79138.0 in Q1 2026, from $139840.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $407936.0 in Q3 2024 to a low of $8901.0 in Q1 2023.
- A 5-year average of $112779.0 and a median of $94229.0 in 2025 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2023 — Capital Expenditures tumbled 92.61% — and 2024, when it jumped 1401.48%.
- Tracing FEMY's Capital Expenditures over 5 years: stood at $93877.0 in 2022, then tumbled by 52.17% to $44899.0 in 2023, then surged by 137.85% to $106792.0 in 2024, then surged by 30.95% to $139840.0 in 2025, then plunged by 43.41% to $79138.0 in 2026.
- The last three Capital Expenditures figures came in at $79138.0 (Q1 2026), $139840.0 (Q4 2025), and $194333.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.51 Bn | 127.30 Bn | 1.96 Bn | 112.60 Mn |
| 2 | Becton Dickinson | 51.76 Bn | 50.90 Bn | 2.32 Bn | 143.00 Mn |
| 3 | Alcon | 35.39 Bn | 34.04 Bn | 1.68 Bn | 374.00 Mn |
| 4 | Resmed | 33.45 Bn | 31.98 Bn | 861.22 Mn | 51.13 Mn |
| 5 | Medline | 28.29 Bn | 25.61 Bn | 2.22 Bn | 111.00 Mn |
| 6 | West Pharmaceutical Services | 24.92 Bn | 24.49 Bn | 329.20 Mn | 43.20 Mn |
| 7 | Solventum | 15.28 Bn | 14.88 Bn | 1.29 Bn | 83.00 Mn |
| 8 | Cooper Companies | 14.77 Bn | 14.63 Bn | 735.40 Mn | 86.40 Mn |
| 9 | Baxter International | 13.51 Bn | 11.36 Bn | 1.03 Bn | 116.00 Mn |
| 10 | Femasys | 9.72 Mn | 8.28 Mn | 189,391.00 | 9,402.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79,138.00 |
| Mar 31, 2026 | 79,138.00 |
| Dec 31, 2025 | 139,840.00 |
| Dec 31, 2025 | 139,840.00 |
| Sep 30, 2025 | 194,333.00 |
| Sep 30, 2025 | 194,333.00 |
| Jun 30, 2025 | 94,229.00 |
| Jun 30, 2025 | 94,229.00 |
| Mar 31, 2025 | 96,605.00 |
| Mar 31, 2025 | 96,605.00 |
| Dec 31, 2024 | 106,792.00 |
| Dec 31, 2024 | 106,792.00 |
| Sep 30, 2024 | 407,936.00 |
| Sep 30, 2024 | 407,936.00 |
| Jun 30, 2024 | 182,421.00 |
| Jun 30, 2024 | 182,421.00 |
| Mar 31, 2024 | 64,557.00 |
| Mar 31, 2024 | 64,557.00 |
| Dec 31, 2023 | 44,899.00 |
| Dec 31, 2023 | 44,899.00 |